9-[[4-(4-amino-1-methylimidazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-7H-purin-8-one;ethane
C27H31N7O — CID 145315492
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[[4-(4-amino-1-methylimidazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-7H-purin-8-one;ethane
9-[[4-(4-amino-1-methylimidazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-7H-purin-8-one;ethane (PubChem CID 145315492) has the molecular formula C27H31N7O and a molecular weight of 469.59 g/mol. Its IUPAC name is 9-[[4-(4-amino-1-methylimidazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-7H-purin-8-one;ethane.
Molecular Properties
| Compound Name | 9-[[4-(4-amino-1-methylimidazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-7H-purin-8-one;ethane |
|---|---|
| PubChem CID | 145315492 |
| Molecular Formula | C27H31N7O |
| Molecular Weight | 469.59 g/mol |
| Exact Mass | 469.26 |
| IUPAC Name | 9-[[4-(4-amino-1-methylimidazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-7H-purin-8-one;ethane |
| SMILES | CC.CC(C)c1ccccc1-c1ncc2[nH]c(=O)n(Cc3ccc(-c4nc(N)cn4C)cc3)c2n1 |
| InChI | InChI=1S/C25H25N7O.C2H6/c1-15(2)18-6-4-5-7-19(18)22-27-12-20-24(30-22)32(25(33)28-20)13-16-8-10-17(11-9-16)23-29-21(26)14-31(23)3;1-2/h4-12,14-15H,13,26H2,1-3H3,(H,28,33);1-2H3 |
| InChIKey | MMNGZUZFRFVSJM-UHFFFAOYSA-N |
| XLogP | 4.97 |
| TPSA | 107.41 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 469.59 |
| LogP ≤ 5 | 4.97 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 145315492 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.